Atheroslerosis, cognitive impairment, and depression in old age. by Vinkers, D.J.
Chapter 9 
Disentangling the relation between atherosclerosis, cognitive impairment, and 
depression in old age 
Vinkers DJ, van der Mast RC, Stek ML, W estendorp RGJ, Gussekloo J. 
Disentangling the relation between atherosclerosis, cognitive impairment,  
and late-onset depression. 
Chapter 9 
86
Disentangling the relation between atherosclerosis, cognitive impairment, and depression in 
old age
87
Abstract
It has been proposed that atherosclerosis is a common causal pathway of cognitive 
impairment and late-onset depression, explaining their common co-occurrence in old age. We 
present a summary of our findings within the Leiden 85-plus Study and reviewed the existing 
literature regarding this relation. In both the Leiden 85-plus Study and the literature, we found 
strong evidence for a causal relationship between atherosclerosis and cognitive impairment, 
but not for a causal relationship between atherosclerosis and late-onset depression. It is likely 
that cognitive impairment contributes to the development of late-onset depression and not the 
other way round. Possible clinical implications of this proposed view are that the prevention 
of atherosclerosis prevents cognitive impairment in old age, which, in turn, may forestall late-
onset depression.
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Introduction
Both cognitive impairment and depression are highly prevalent in elderly subjects, and 
account for a large part of the burden of disability and use of healthcare resources in old age
1
.
Moreover, cognitive decline and depression frequently co-occur in old age, while showing 
substantial overlap in signs and symptoms
2 3 4
. Therefore, it has even been suggested that 
atherosclerosis, being a final common pathway, leads to both cognitive impairmant and late-
onset depression (figure 9.1)
5 6 7
. Here, we present a review of our findings in the Leiden 85-
plus Study combined with a review of the existing literature about the relationship between 
atherosclerosis on the one hand and cognitive impairment and late-onset depression on the 
other hand.
Figure 9.1 Current understanding of the relation between atherosclerosis, cognitive impairment, and 
late-onset depression. It has been proposed that atherosclerosis is a common causal pathway of 
cognitive impairment5 and late-onset depression6, explaining their common co-occurrence in old age7.
Atherosclerosis and cognitive impairment
The major types of dementia in old age are Alzheimer's disease and vascular dementia
8
.
Clinically, both dementias are characterized by cognitive impairment interfering with daily 
functioning. Since many years atherosclerosis is regarded as the cause of vascular dementia, 
while by definition, atherosclerosis does not play a role in Alzheimer's disease
9
. Etiologically, 
both dementias may however not be as different as has been proposed in clinical 
classifications of dementia
10
.
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There is accumulating evidence that atherosclerosis is also involved in the etiology of 
Alzheimer's disease. First, in post-mortem analyses, the pathological characteristics of 
Alzheimer's disease are frequently observed in combination with manifestations of 
atherosclerosis
11 12 13 14
. Second, indicators of atherosclerosis such as vessel wall thickness 
and carotid artery plaques are associated with Alzheimer's disease
15 16 17
, although this has not 
yet been shown prospectively. Third, well known cardiovascular risk factors including 
smoking and hypertension and have been related to the development of Alzheimer's disease
18
19 20 21
.  Indeed, treatment of blood pressure prevents the occurrence of Alzheimer's disease in 
elderly subjects
22 23 24
. Furthermore, hypercholesterolemia is associated with an increased 
incidence of Alzheimer's disease in observational studies
25 26
. Clinical trails could, however, 
not confirm that cholesterol lowering therapy protects against cognitive decline
27 28 29
.
Possibly, hypercholesterolemia is treated in healthy subjects only, explaining the difference 
between observational studies and clinical trials. Fourth, the most important genetic risk 
factor for the occurrence of Alzheimer disease is the APOE4 gene, which is also linked to 
atherosclerosis
30 31 32 33
. Fifth, cerebral white matter hyperintensities, that are assumed to have 
a vascular ischemic origine
34
, are frequently observed on magnetic resonance imaging (MRI)
scans of subjects with Alzheimer's disease
35
. Finally, brain infarctions exacerbate the clinical 
expression of Alzheimer's disease 
36 37 38
. Thus, there is strong evidence that atherosclerosis is 
an important causal factor in both vascular dementia and Alzheimer's disease, leading to 
cognitive impairment in old age
39 40 41
. Several prospective studies indeed confirmed a 
longitudinal relation between cumulative measurements of vascular disease and the 
occurrence of cognitive decline in elderly subjects
42 43 44
.
Within the population-based Leiden 85-plus Study, we prospectively followed 599 subjects 
from age 85 years onwards with annual assessments of various cognitive domains. At age 85 
years, the burden of atherosclerosis including myocardial infarction, angina pectoris or 
myocardial ischemia, claudicatio intermittens, and arterial surgery was assessed by history 
taking and electrocardiography. Cross-sectionally, atherosclerosis was related to a more 
impaired global cognitive function, lesser attention, and a slower processing speed
45
. During 
five years of follow-up, atherosclerosis was related to an accelerated decline of immediate 
recall memory and delayed recall memory
46
. The relation between atherosclerosis and 
cognitive impairment was unaffected by adjustment for depressive symptoms, a history of 
stroke, or presence of chronic diseases. Thus, in the oldest old, atherosclerosis contributed 
independently to cognitive decline.
Atherosclerosis and late-onset depression
The clinical picture of late-onset depression differs from that of early-onset depression. Late-
onset depression is characterized by apathy, loss of interest and energy, psychomotor 
retardation and impairment of executive functioning rather than by mood disturbances, 
feelings of depreciation and guilt, and suicidal ideation
47
. Besides, late-onset depression has, 
contrary to early-onset depression, not been associated with a family history of mood 
disorders
48
. It has therefore been suggested that early-onset and late-onset depression have 
distinct etiologies
49
. Elderly subjects may be more vulnerable to depression because of age-
related structural brain changes due to atherosclerotic or degenerative damage
50
. This notion 
is consistent with the vascular depression hypothesis supposing cerebrovascular lesions to 
predispose, precipitate, or perpetuate late-onset depression
6
.
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There is little direct evidence however for the vascular depression hypothesis. First, although 
there is a co-occurence of late-onset depression and cardiovascular events
51 52 53
, it is likely 
that this co-occurrence reflects the psychological undermining of the inflicted patient. This is 
supported by the relation between the amout of physical and social disability after the onset of 
cardiovascular diseases and the subsequent emergence and course of depression
54 55 56 57 58 59
60 61
. Approximately half of all depressed subjects improve rapidly after the onset of a 
cardiovascular disease
62
. No relationships have been found between well known 
cardiovascular risk factors as hypertension and hypercholesterolemia and late-onset 
depression
63 64 65 66 67 68
, and the treatment of hypertension and hypercholesterolemia does 
indeed not reduce late-onset depression
69 70
. Furthermore, various studies showed that the 
number of vascular diseases and vascular risk factors are not related to late-onset depression
71
72 73 74 75
, although not unequivocally
76
, or a relation which disappeared after adjustment for 
disability
77 78
. Second, although late-onset depression is cross-sectionally associated with 
white matter hyperintensities on magnetic resonance imaging (MRI) scans of the brain
79 80 81
82 83 84 85 86
, there is hitherto no evidence that white matter hyperintensities cause late-onset 
depression prospectively. Furthermore, the association between white matter hyperintensities 
and late-onset depression disappears after adjustment for functional impairment
87 88 89
, which 
may be explained by the relation between white matter hyperintensities and functional 
disability
90 91
, gait and balance dysfunction
92 93 94
, urinary incontinence
95 96
, and decreased 
pulmonary function
97
. Third, white matter hyperintensities in depressed elderly are often 
located at the level of the dorsolateral prefrontal cortex
98 99 100 101
, which is biologically 
related to apathy rather than to depression
102 103 104
. Apathy, being a distinct clinical entity 
with different psychopathology, treatment, and prognostic implications, differs from late-
onset depression
105 106
. Fourth, post-mortem analyses show that although there is a relation 
between late-onset depression and post-ischaemic inflammation, no such relation exists 
between late-onset depression and atherosclerosis
107 108
. Fifth, although there is a cross-
sectional association between non-invasive measurements of atherosclerosis and late-onset 
depression, this association may at least partly be explained by functional disability
109
.
Finally, genes which are associated with atherosclerosis, including the APOE4 gene, are not 
related to late-onset depression
110 111 112 113 114
. Taken together, there is no evidence that there 
is a causal relationship between atherosclerosis and late-onset depression. In line, two recent 
reviews on this topic concluded that, although there are important interactions between 
atherosclerosis and late-onset depression, the concept of vascular depression may be too 
restrictive
115 116
.
Within the Leiden 85-plus Study, we prospectively followed 599 subjects from age 85 years 
onwards with annual assessments of depressive symptoms. The burden of atherosclerosis at 
baseline was assessed by history taking and electrocardiography. During five years of follow-
up, there was a highly significant increase of depressive symptoms, but no relation existed 
between the burden of atherosclerosis and depressive symptoms, neither cross-sectionally nor 
longitudinally
46
. Thus, in the oldest old, atherosclerosis did not contribute to the development 
of depression.
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Temporal relationship between cognitive impairment and late-onset 
depression
Clinical experience and research evidence learns that, in old age, signs and symptoms of 
cognitive impairment are difficult to distinguish from depression, and that cognitive 
impairment and depression frequently co-occur
2 3 4
. The temporal relation between them 
remains, however, unclear since most studies examined only the relationship of depression 
with the subsequent development of cognitive impairment
117 118 119 120 121 122
. Causal inference 
of these studies is hampered by the possibility that depression may be an early sign instead of 
an independent risk factor for cognitive impairment. Hitherto, one large population-based 
study studied the temporal relation between cognitive impairment and depression in elderly 
subjects. This study found that depression is an early manifestation rather than a predictor of 
cognitive impairment
123
. The view that late-onset depression is a concomitant phenomenon of 
cognitive decline is further supported by the finding that succesful treatment of late-life 
depression does not lead to significant cognitive improvement
124 125 126
.  Furthermore, 
neuropathological studies showed that the association between cognitive impairment and 
depression in elderly subjects could not be explained by a common etiology as cerebral 
infarctions
127
, cortical plaques and tangles
128
, or loss of serotonergic
129
 and noradrenergic 
neurons
130
. These findings make it again less likely that atherosclerosis is a common causal 
pathway of cognitive impairment and late-onset depression. 
Within the Leiden 85-plus Study, we examined the temporal relation between various 
cognitive domains and depressive symptoms
131
. Cross-sectionally, cognitive impairment and 
depressive symptoms were highly significant correlated. Impairment of attention, immediate 
recall memory, and delayed recall memory at baseline were associated with an accelerated 
increase of depressive symptoms during follow-up. In contrast, depressive symptoms at 
baseline were not associated with an accelerated cognitive decline during follow-up. Thus, in 
the oldest old, cognitive impairment preceded the onset of depressive symptoms and not the 
other way round. 
In conclusion, we presented a summary of our findings within the Leiden 85-plus Study and 
reviewed the existing literature about the relation between atherosclerosis, cognitive 
impairment, and late-onset depression. We found strong evidence for a causal relationship 
between atherosclerosis and cognitive impairment, but not for a causal relationship between 
atherosclerosis and late-onset depression. Furthermore, it is likely that cognitive impairment 
contributes to the development of late-onset depression and not the other way round (figure 
9.2). Clinical implications of this proposed view are that although depression and cognitive 
impairment frequently co-occur in old age, the presence of late-onset depression only does not 
mean that cognitive decline is yet to come. The prevention of atherosclerosis may prevent 
cognitive impairment in old age, and this, in turn, may forestall late-onset depression.  
Figure 9.2 Proposed relation between atherosclerosis, cognitive impairment, and late-onset depression. 
Atherosclerosis is related to cognitive impairment, but not to late-onset depression46. Cognitive 
impairment contributes to the development of late-onset depression131.
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